{"paper_id": "ac4d3bca00759d99a510aa08a722ea67eeae1ee3", "metadata": {"title": "Supplementary Material and Methods", "authors": []}, "abstract": [], "body_text": [{"text": "Huh7-Lunet cells. Cells were seeded and harvested as described recently (2) . The protocols for measurement of Firefly and Renilla-luciferase activity were described elsewhere (3) .", "cite_spans": [{"start": 72, "end": 75, "text": "(2)", "ref_id": "BIBREF1"}, {"start": 176, "end": 179, "text": "(3)", "ref_id": "BIBREF2"}], "ref_spans": [], "section": ""}, {"text": "Colony formation assay. Huh7-Lunet cells were electroporated with 1, 0.1 or 0.025\u00b5g in vitro transcribed RNA of blasticidin-selectable HAV or HCV replicon constructs (BlrHAV, BlrCon1) or respective replication-deficient controls (BlrHAVmut, BlrCon1GND). Cells were seeded on 10cm culture-dishes and medium containing 2.5\u00b5g/ml blasticidin (Thermo Fisher Scientific, Darmstadt, Germany) was replaced twice per week. After two (BlrCon1) or three (BlrHAV) weeks, when control-plates were empty, colonies were stained with Coomassie-Brilliant-Blue solution and counted with the multi-point tool of ImageJ software (Maryland, USA).", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "To control for cell viability with cell proliferation reagent WST-1 (Roche, Germany), Huh7-Lunet cells were seeded in triplicates (10000 cells per well) on a 96well plate. A detailed description of the protocol is included in (2) .", "cite_spans": [{"start": 226, "end": 229, "text": "(2)", "ref_id": "BIBREF1"}], "ref_spans": [], "section": "Cell viability."}, {"text": "firefly-luciferase reporter replicon pT7-18f-LUC and replication-deficient pT7-18f-LUCmut plasmids (3), derived from the cell culture adapted HAV strain HM175 18f (GenBank accession no. M59808), were used to produce subgenomic reporter replicon RNA referred to as LucHAV / HAV or LucHAVmut / HAVmut. ). For generation of blasticidin selectable sugenomic replicons (BlrHAV, BlrHAVmut, BlrCon1, BlrCon1GND), the firefly-luciferase gene was replaced by blasticidin-S-deaminase gene (Blr) by PCR directed cloning, using BbvCI and SacI restriction sites flanking the Blrgene. For generation of pFK_i389RenillaLucNS3-3'_JFH_dg (referred to as RLucJFH), the Renilla-luciferase gene was amplified by PCR from pFKI389RLuc2ACore-3\u2032-Jc1 plasmid (3) using primers S_RLuc_AscI (ATGGGCGCGCCATGACTTCGAAAGTTTATGATC) and A_RLuc_NotI (TCTGCGGCCGCTTATTGTTCATTTTTGAGAACTCG), digested with AscI and NotI and ligated into the AscI, NotI digested pFKi389FLuc NS3-3\u00b4JFH or pFKi389FLuc NS3-3\u00b4JFH dGDD plasmids (2) . The R-LucJFH X-tail Con1 chimera (pFK_i389RenillaLucNS3-3'_JFH X-tail Con1_dg) was generated by digesting pFK_i341", "cite_spans": [{"start": 985, "end": 988, "text": "(2)", "ref_id": "BIBREF1"}], "ref_spans": [], "section": "Plasmid constructs and cell based replication assays. Replication-competent HAV"}, {"text": "PiLucNS3-3'_dg_JFH_Xcon (4) with NsiI and MluI and ligation of the fragment containing the X-tail into NsiI and MluI digested pFK_i389RenillaLucNS3-3'_JFH_dg.", "cite_spans": [], "ref_spans": [], "section": "Plasmid constructs and cell based replication assays. Replication-competent HAV"}, {"text": "Generation of PI4KIII\u03b2 knockout cells. Huh7-Lunet cells stably expressing T7polymerase under zeocin-selection have been described before (5) . Single guide RNAs (sgRNA) for CRISPR-Cas9-mediated knockout of PI4KIII\u03b2 were designed using the Ecrisp online tool (www.e-crisp.org). Lyophilized oligonucleotides (Sigma-Aldrich, Steinheim, Germany) harboring the sgRNA sequence (TGCACTGAGGAATGCCTCAGTGG) and additional 5' (CACC) or 3' (CAAA) restriction site overhangs for BsmBI were resuspended at 50\u00b5M in 5mM Tris-HCl and boiled for 5min at 95\u00b0C before slowly cooling down to room temperature for nucleotide annealing.", "cite_spans": [{"start": 137, "end": 140, "text": "(5)", "ref_id": "BIBREF4"}], "ref_spans": [], "section": "Plasmid constructs and cell based replication assays. Replication-competent HAV"}, {"text": "25pmol of the annealed oligonucleotides were used for 5' phosphorylation by incubation with T4 polynucleotide kinase for 1h at 37\u00b0C. 0.5pmol of the phosphorylated oligonucleotides were ligated into the BsmBI-digested lentiCRISPR vector, which allows parallel delivery of Cas9 nuclease together with the sgRNA to the target cells (6) . Lentiviral particles were produced as described before (5) ", "cite_spans": [{"start": 329, "end": 332, "text": "(6)", "ref_id": null}], "ref_spans": [], "section": "Plasmid constructs and cell based replication assays. Replication-competent HAV"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes", "authors": [{"first": "M", "middle": [], "last": "Schmitt", "suffix": ""}, {"first": "N", "middle": [], "last": "Scrima", "suffix": ""}, {"first": "D", "middle": [], "last": "Radujkovic", "suffix": ""}, {"first": "C", "middle": [], "last": "Caillet-Saguy", "suffix": ""}, {"first": "P", "middle": ["C"], "last": "Simister", "suffix": ""}, {"first": "P", "middle": [], "last": "Friebe", "suffix": ""}], "year": 2011, "venue": "J Virol", "volume": "85", "issn": "6", "pages": "2565--2581", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B", "authors": [{"first": "K", "middle": [], "last": "Esser-Nobis", "suffix": ""}, {"first": "I", "middle": [], "last": "Romero-Brey", "suffix": ""}, {"first": "T", "middle": ["M"], "last": "Ganten", "suffix": ""}, {"first": "J", "middle": [], "last": "Gouttenoire", "suffix": ""}, {"first": "C", "middle": [], "last": "Harak", "suffix": ""}, {"first": "R", "middle": [], "last": "Klein", "suffix": ""}], "year": 2013, "venue": "Hepatology", "volume": "57", "issn": "3", "pages": "953--963", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment", "authors": [{"first": "S", "middle": [], "last": "Reiss", "suffix": ""}, {"first": "I", "middle": [], "last": "Rebhan", "suffix": ""}, {"first": "P", "middle": [], "last": "Backes", "suffix": ""}, {"first": "I", "middle": [], "last": "Romero-Brey", "suffix": ""}, {"first": "H", "middle": [], "last": "Erfle", "suffix": ""}, {"first": "P", "middle": [], "last": "Matula", "suffix": ""}], "year": 2011, "venue": "Cell Host Microbe", "volume": "9", "issn": "1", "pages": "32--45", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras", "authors": [{"first": "M", "middle": [], "last": "Binder", "suffix": ""}, {"first": "D", "middle": [], "last": "Quinkert", "suffix": ""}, {"first": "O", "middle": [], "last": "Bochkarova", "suffix": ""}, {"first": "R", "middle": [], "last": "Klein", "suffix": ""}, {"first": "N", "middle": [], "last": "Kezmic", "suffix": ""}, {"first": "R", "middle": [], "last": "Bartenschlager", "suffix": ""}], "year": 2007, "venue": "J Virol", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF4": {"ref_id": "b4", "title": "Role of annexin A2 in the production of infectious hepatitis C virus particles", "authors": [{"first": "P", "middle": [], "last": "Backes", "suffix": ""}, {"first": "D", "middle": [], "last": "Quinkert", "suffix": ""}, {"first": "S", "middle": [], "last": "Reiss", "suffix": ""}, {"first": "M", "middle": [], "last": "Binder", "suffix": ""}, {"first": "M", "middle": [], "last": "Zayas", "suffix": ""}, {"first": "U", "middle": [], "last": "Rescher", "suffix": ""}], "year": 2010, "venue": "J Virol", "volume": "84", "issn": "11", "pages": "5775--5789", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Genome-scale CRISPR-Cas9 knockout screening in human cells", "authors": [], "year": 2014, "venue": "Science", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "Improving proteolytic cleavage at the 3A/3B site of the hepatitis A virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC", "authors": [{"first": "Y", "middle": [], "last": "Kusov", "suffix": ""}, {"first": "V", "middle": [], "last": "Gauss-Muller", "suffix": ""}], "year": 1999, "venue": "J Virol", "volume": "", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "Huh7 or Huh7-Lunet cells or 1.5x10^7 Huh7.5, Hep3B or Huh6 cells were resuspended in 1ml cytomix. 5\u00b5g of subgenomic replicon RNA were used for transfection of 400\u00b5l of single cell suspension. For miR122 experiments 100pmol of miR122 or the mutant miR122_A4U were coelectroporated with 5\u00b5g of in vitro transcribed RNA into Hep3B cells. For mirVana experiments 240pmol of the miR122 antagonist or 240pmol miR122_A4U were coelectroporated together with 5\u00b5g of subgenomic replicon RNA into", "latex": null, "type": "figure"}, "FIGREF1": {"text": "and transduced Huh7-Lunet T7 cells were selected using 2\u00b5g/ml puromycin. The selected cell population typically represents a pool of cells with varying knockout efficiencies depending on the number of defective gene alleles after cleavage by Cas9 and religation. To obtain clones with complete PI4KIII\u03b2 knockout, single cells were seeded together with na\u00efve Huh7-Lunet cells in 96-well plates. After 48h, puromycin was added to remove the non-resistant cells and the remaining clonal colonies were cultivated and expanded. PI4KIII\u03b2 levels in the obtained cell clones were analyzed by Western-Blotting using monoclonal mouse antibodies directed against PI4KIII\u03b2 (BD Bioscience) or \u03b2-Actin (Sigma-Aldrich, Steinheim, Germany), respectively. The blot was documented with an INTAS ECL ChemoCam Imager (INTAS Science Imaging, Germany). Immunofluorescence. Huh7-Lunet cells were seeded on glass coverslips upon coelectroporation with F-LucHAV and R-LucJFH or R-LucJFH Xtail Con1 or mock electroporation. Alternatively, Huh7-Lunet T7 cells (stably expressing T7 polymerase) were seeded onto glass coverslips and transfected 24h later with expression plasmids pTM_2A-3D_HAV or pTM_NS3-5B_HCV (gt2a, JFH1) by using TransTILT1 transfection reagent (Mirus, Bio, LLC, Madison, WI) according to the instructions of the manufacturer. The protocol used for immunofluorescence has been described before (5). In brief, cells were fixed for 15min using 4% paraformaldehyde (PFA) followed by permeabilization with 50\u00b5g/ml digitonin for 15min at room temperature. Upon blocking for 20min with PBS containing 3% bovine serum albumin (BSA), coverslips were incubated with mouse monoclonal 9E10 (generous gift of Charles M. Rice and Timothy Tellinghuisen) specific for HCV NS5A, rabbit polyclonal anti-3C antibody (7) and labeled secondary antibodies (goat-anti-rabbit conjugated to Alexa-Fluor 488, donkey-antimouse conjugated to Alexa-Fluor 568 (both Invitrogen, Karlsruhe, Germany)). For labelling of mitochondria, MitoTracker (Invitrogen) was added at a dilution of 1:10.000 to the cells prior to fixation and incubated for 30min at 37\u00b0C. Samples were mounted in Fluoromount G (Southern Biotechnology Associates, Birmingham, AL, USA). Pictures of the samples were taken at a Leica SP2 microscope equipped with a 63x oil immersion objective using the Leica Confocal software LCS (Leica, Heidelberg, Germany) and merged using Fiji software (NIH). For quantitative analysis of colocalization at least 14 cells per condition were analyzed. Colocalization was determined with the intensity correlation analysis function of Fiji software. Statistical data analysis was performed with the Graph-Pad Prism 5 software package using the unpaired t test (GraphPad Software,Inc., La Jolla, CA) as described before(2).", "latex": null, "type": "figure"}, "FIGREF2": {"text": "HAV RNA replication is independent of miR122. (A) Huh6 cells support HAV and HCV gt2a RNA replication. Huh6 cells were electroporated with the indicated replicon RNAs and luciferase activity was measured 4, 24, 48 and 72h later (r.l.u.) and normalized to the 4h value. Depicted are the mean and SD of two independent experiments performed with triplicates. Data are presented in logarithmic scale. (n=2). Note that the replication-deficient HAVmut is used as negative control. (B) The indicated reporter replicons were electroporated either alone or together with the miR122 antagonist mirVana or the mutant miR122_A4U into Huh7-Lunet cells. Replication (luciferase activity, r.l.u.) was determined 4, 24, 48 and 72h upon electroporation. Data are derived from two independent experiments performed in triplicates and depicted in logarithmic scale. The graph shows mean and SD of raw data (r.l.u.) because miR122 impacts on HCV translation. (n=2) Cytostatic effects of different reagents on Huh7-Lunet cells. (A) Huh7-Lunet cells were treated for 48h with different inhibitors at the indicated concentrations. Note that all concentrations are given in [\u00b5M] with exception of DMSO [%]. 48h after addition of different compounds, cell proliferation reagent WST-1 was added and incubated at 37\u00b0C. To determine the number of viable cells, absorbance at 450nm was measured 30 and 60min later. Data are derived from two independent experiments performed in triplicates and normalized to the untreated control (wo). A drug concentration was assessed as cytostatic, when the absorbance dropped below 80%. (n=2) HAV RNA replication is independent of CypA but sensitive to the ABCtransporter inhibitor PSC833. (A) Huh7-Lunet cells either expressing a non-targeting shRNA (shONT) or a shRNA targeting CypA were electroporated with the indicated reporter replicons. Replication was measured 4, 24, 48 and 72h after electroporation and normalized to the 4h value. The graph shows mean and SD of two independent experiments performed with triplicates. Data are depicted in logarithmic scale. (n=2) (B) Huh7-Lunet cells were electroporated with HAV or HCV subgenomic reporter replicons. 4h p.t. cells were treated with the indicated concentrations of PSC833. 48h after treatment cells were lysed to measure luciferase activity. Note, that the number of viable cells was reduced to 60% by 8\u00b5M of PSC833 (also Figure S2). The graph shows mean and SD of two independent experiments performed with triplicates and normalized to the untreated control. Data are depicted in logarithmic scale. (n=2) Viral non-structural proteins 5A (HCV) and 3C (HAV) do not colocalize upon coexpression. (A and B) The lower panels represent magnifications of the boxed areas, with arrows indicating the lines used for plot profile analyses represented on the right. Scale bars, 10\u00b5m. (A) Immunofluorescence analysis of Huh7-Lunet T7 cells 24h upon cotransfection with plasmids encoding HCV NS3-5B or HAV 2A-3D, using mouse monoclonal anti-NS5A antibody and rabbit polyclonal anti-3C antibody. (B) 24h upon transfection of Huh7-Lunet cells with HAV 2A-3D, mitochondria were labeled with MitoTracker and immunofluorescence was performed using rabbit polyclonal anti-3C antibody. (C) Colocalization analysis for HCV-5A / HAV-3C (left) and mitochondria / HAV-3C (right). The graph depicts mean and SD of the Pearson correlation coefficient (Rr) of at least 14 analyzed cells per condition. ***, p<0.0001", "latex": null, "type": "figure"}, "TABREF0": {"text": "Reagents used throughout the study", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Reagent </td><td>\u00a0</td><td>Source </td><td>\u00a0</td><td>Stock concentration and solvent </td></tr><tr><td>Recombinant </td><td>human interferon </td><td>PBL Interferon Source, USA </td><td>1000U/\u00b5l in DMEM </td></tr><tr><td>alpha 2a (IFNalpha) </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Recombinant lambda (IFNlambda) </td><td>human interferon human interferon </td><td>Pepro Tech, Hamburg, Germany </td><td>200\u00b5g/ml in DMEM </td></tr><tr><td>Recombinant gamma (IFNgamma) </td><td>R&amp;D systems, Germany </td><td>100\u00b5g/ml in H2O </td></tr><tr><td>Legalon-SIL (SIL) </td><td>Madaus, Cologne, Germany </td><td>28.5mg/ml in H2O </td></tr><tr><td>Silibinin </td><td>\u00a0</td><td>Sigma Aldrich, Steinheim, Germany </td><td>25mg/ml in DMSO </td></tr><tr><td>AL-9 </td><td>\u00a0</td><td>Provided by Raffaele De Francesco, </td><td>10mM in DMSO </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Milan, Italy </td><td>\u00a0</td></tr><tr><td>PIK93 </td><td>\u00a0</td><td>Sigma Aldrich, Steinheim, Germany </td><td>3mg/ml </td></tr><tr><td>Cyclosporin A (CsA) </td><td>Sigma Aldrich, Steinheim, Germany </td><td>20mg/ml in DMSO </td></tr><tr><td>NIM811 </td><td>\u00a0</td><td>Novartis, Basel, Switzerland </td><td>10mg/ml in DMSO </td></tr><tr><td>Sanglifehrin A (SFA) </td><td>Novartis, Basel, Switzerland </td><td>20mg/ml in DMSO </td></tr><tr><td>Reversan </td><td>\u00a0</td><td>Sigma Aldrich, Steinheim, Germany </td><td>19mM in DMSO </td></tr><tr><td>Piperine </td><td>\u00a0</td><td>Sigma Aldrich, Steinheim, Germany </td><td>199mM in DMSO </td></tr><tr><td>FK506 (Tacrolimus) </td><td>InvivoGen, San Diego, USA </td><td>20mM in DMSO </td></tr><tr><td>PSC833 (Valspodar) </td><td>Santa Cruz Biotechnology, Dallas, </td><td>5mg/ml in DMSO </td></tr><tr><td>USA </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>miR122: </td><td>mirVana, miRNA inhibitor </td><td>Invitrogen, Karlsruhe, Germany </td><td>100\u00b5M in H2O </td></tr><tr><td>\u00a0</td><td>Eurofins Genomics, </td><td>Ebersberg, </td><td>50\u00b5M in H2O </td></tr><tr><td>UGGAGUGUGACAAUGGUGUUU\n</td><td>Germany </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>GU </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>miR122 A4U: </td><td>\u00a0</td><td>Eurofins Genomics, </td><td>Ebersberg, </td><td>50\u00b5M in H2O </td></tr><tr><td>UGGUGUGUGACAAUGGUGUUU\n</td><td>Germany </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>GU </td></tr></table></body></html>"}, "TABREF1": {"text": "Compounds used for inhibition of HCV or HAV RNA replication and corresponding", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>LucHAV </td><td>LucJFH </td><td>LucCon1 </td><td>LucH77 </td></tr><tr><td>Inhibitor </td><td>IC90 </td><td>IC90 </td><td>IC90 </td><td>IC90 </td></tr><tr><td>(95% CI) </td><td>(95% CI) </td><td>(95% CI) </td><td>(95% CI) </td></tr><tr><td>IFNalpha [IU/ml] </td><td>14.64 </td><td>20.19 </td><td>9.38 </td><td>11.87 </td></tr><tr><td>(4.33 to 49.81) </td><td>(13.95 to 29.23) </td><td>(6.1 to 14.5) </td><td>(7.8 to 18.1) </td></tr><tr><td>IFNlambda [ng/ml] </td><td>14.68 </td><td>16.9 </td><td>2.73 </td><td>3.73 </td></tr><tr><td>(4.33 to 49.81) </td><td>(7.91 to 36.09) </td><td>(1.71 to 4.38) </td><td>(2.35 to 5.92) </td></tr><tr><td>IFNgamma [ng/ml] </td><td>0.17 </td><td>0.39 </td><td>0.11 </td><td>0.15 </td></tr><tr><td>(0.05 to 0.52) </td><td>(0.29 to 0.52) </td><td>(0.05 to 0.27) </td><td>(0.07 to 0.31) </td></tr><tr><td>Silibinin [\u00b5g/ml] </td><td>44.4 </td><td>n.a. </td><td>n.a. </td><td>n.a. </td></tr><tr><td>(36.59 to 53.87) </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>CsA [\u00b5M] </td><td>8.96 </td><td>2.74 </td><td>&lt;1 </td><td>2.05 </td></tr><tr><td>(6.02 to 13.34) </td><td>(2.55 to 2.96) </td><td>\u00a0</td><td>(1.75 to 2.40) </td></tr><tr><td>NIM811 [\u00b5M] </td><td>9.92 </td><td>0.83 </td><td>&lt;1 </td><td>&lt;1 </td></tr><tr><td>(5.96 to 16.53) </td><td>(0.23 to 2.96) </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>SFA [\u00b5M] </td><td>n.a. </td><td>18.1 </td><td>&lt;4 </td><td>13.5 </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>(15.94 to 20.48) </td><td>\u00a0</td><td>(11.17 to 16.31) </td></tr><tr><td>Reversan [\u00b5M] </td><td>13.23 </td><td>n.a. </td><td>9.45 </td><td>21.48 </td></tr><tr><td>(9.61 to 18.21) </td><td>\u00a0</td><td>(7.09 to 11.54) </td><td>(15.51 to 29.75) </td></tr><tr><td>Piperine [\u00b5M] </td><td>76.03 </td><td>n.a. </td><td>32.15 </td><td>n.a. </td></tr><tr><td>(60.12 to 96.16) </td><td>\u00a0</td><td>(27.88 to 37.08) </td><td>\u00a0</td></tr><tr><td>FK506 [\u00b5M] </td><td>19.97 </td><td>n.a. </td><td>n.a. </td><td>n.a. </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>(17.20 to 23.17) </td></tr></table></body></html>"}}, "back_matter": []}